TRT denied as not medically necessary by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for trt are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Denies Testosterone Replacement Therapy for Medical Necessity — and How to Appeal

Testosterone replacement therapy (TRT) treats hypogonadism — a condition in which the body does not produce sufficient testosterone — and is available in several FDA-approved formulations. UnitedHealthcare's medical-necessity denials for TRT most commonly occur when the clinical documentation submitted does not clearly satisfy every criterion in UHC's published coverage policy: for example, insufficient laboratory evidence, inadequate documentation of symptoms, absence of a documented confirmatory evaluation, or failure to rule out reversible secondary causes.

### Why This Denial Is Appealable

Medical-necessity denials are clinical determinations, not administrative ones, and they require clinical reviewers to apply the plan's criteria to your actual record. If the denial is based on documentation gaps — rather than a genuine finding that you do not meet criteria — a supplemented appeal that fills those gaps with specific chart evidence can succeed. If UHC's criteria are more restrictive than the applicable professional guideline organization's standards, an external reviewer applying evidence-based standards (rather than the plan's internal policy) may reach a different result.

### Federal Appeal Framework

• Internal appeal (Level 1): Written internal appeal required first. UHC must decide standard appeals within 30 days and expedited appeals within 72 hours.
• External review (ACA §2719): After final internal denial, you may request independent external review. The IRO applies clinical evidence standards and is not bound by UHC's internal coverage definitions.
• ERISA §503: Employer-plan members are entitled to full-and-fair review, including written disclosure of every criterion applied and every clinical reference cited.
• Timeline: External review is generally available for approximately four months after the final internal denial. Expedited external review is available when delay poses risk to health.

### Concrete Appeal Steps

1. Request the full denial letter and UHC's published clinical coverage policy for TRT — both the criteria and the clinical references cited. 2. With your prescriber, audit your chart against every listed criterion. 3. Identify any documentation gaps and ask your prescriber to supplement the record with a detailed medical-necessity letter. 4. Submit the internal appeal with all supplemental documentation. 5. If denied, file for external review; include the full appeal record and the FDA prescribing label.

### Documentation to Gather

• Diagnosis confirmation: Chart notes and lab results establishing the clinical diagnosis, including test timing relative to symptoms per the FDA-approved prescribing label's guidance.
• Symptom documentation: Prescriber notes describing the clinical presentation — fatigue, functional impact, and course over time.
• Prior treatment history: Any conservative or reversible interventions explored before TRT, with dates and outcomes.
• Evaluation for secondary causes: Chart notes or referral records showing whether reversible causes were assessed — this is commonly a UHC criterion.
• Prescriber medical-necessity letter: A structured letter mapping each UHC criterion to the corresponding chart finding; referencing the Endocrine Society or other applicable guideline organization generically.

### Criteria-Mapping Structure

Copy each criterion from UHC's coverage policy and answer it with a specific chart fact:

| UHC Medical-Necessity Criterion | Chart Evidence Satisfying It | |---|---| | [Copy each criterion verbatim] | [Specific lab, date, note, or test result] |

Confirm the FDA-approved prescribing label's indication and testing requirements at DailyMed, and ensure your documentation aligns with the labeling language — reviewers will cross-reference it.